Head of Business & Corporate Development

Altus Formulation is an R&D focused pharmaceutical development company with a suite of proprietary drug delivery technologies and a rapidly growing portfolio of co-development and licensing agreements with a range of global partners. Altus is seeking a Head of...

Recipharm Signs Licensing Agreement with Altus Formulation

MONTREAL, QC / ACCESSWIRE / March 5, 2018 / Recipharm, the contract development and manufacturing organisation (CDMO), has signed a licensing agreement with Altus Formulation Inc., a Canadian drug development company, to allow its customers to access new drug delivery...

FLEXITAB Safer Use Extended Release Tablets

Altus is pleased to present FLEXITABTM, an innovative and commercially validated technology platform providing novel, value added life-cycle management opportunities through Safer UseTM breakable, extended release (ER) tablets. Conventional ER tablets may ‘dose dump’...

ALTUS ANNOUNCES ALLOWANCE OF NEW FLEXITABTM PATENTS IN EUROPE

Altus Formulation Inc. a Quebec based drug development company, leveraging its patented delivery technologies to develop novel Safer to UseTM formulations for its partners and their patients is pleased to announce the allowance of its first FLEXITABTM patent in Europe...